EYA1 antibody
Quick Overview for EYA1 antibody (ABIN1714156)
Target
See all EYA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- EYA1 Polyclonal Antibody
-
Cross-Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human EYA1
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- EYA1 (Eyes Absent Homolog 1 (EYA1))
-
Alternative Name
- Eya1
-
Background
-
Synonyms: BOP, BOR, Eya1, EYA1_HUMAN, eyes absent 1, eyes absent 1 homolog, eyes absent homolog 1 Drosophila, Eyes absent homolog 1, eyes absent homolog1, MGC141875.
Background: A gene on chromosome 8q13.3 encodes EYA1 (eyes absent), a protein with 16 exons. EYA1 is one of four members of the eyes absent family. A 271 amino acid domain at the carboxyl terminal is highly conserved amongst the members of the eyes absent family, while the PST (proline-serine-threonin)-rich amino terminal is highly divergent. EYA is expressed in flexor tendons and the developing central nervous system, kidney, eye and ear. EYA1 acts a transcriptional activator in connective tissue patterning through its PST domain, which functions as a transactivation domain. EYA1 plays a critical role in the development of the inner ear and kidney. EYA is involved in early inductive signaling, acting upstream of GDNF. EYA1 has been implicated in the autosomal dominant disorders branchio-oto-renal (BOR) syndrome and branhio-oto (BO) syndrome.
-
Gene ID
- 2138
-
Pathways
- Sensory Perception of Sound, Positive Regulation of Response to DNA Damage Stimulus
Target
-